PAPER
Synthesis of Conformationally Restricted Macrodiolides
2041
13C NMR (50.3 MHz, CDCl3): δ = 14.8 (CH3), 19.4 (CH3), 20.9
(CH3), 24.9 (CH2), 29.5 (CH2), 53.1 (Cq), 63.2 (OCH2), 64.7
(OCH2), 71.4 (OCH), 92.0 (Cq), 111.1 (=CH), 112.7 (Cq), 121.1
(=CH), 124.2 (Cq), 128.9 (=CH), 130.3 (=CH), 156.1 (Cq), 162.4
(COO), 206.9 (C=O).
HRMS (ESI): m/z [M + Na]+ calcd for C37H42O12: 701.2574; found:
701.2571.
(2R,4aS,11aS,14R,15aR,28bR)-2,3,3,13,13,14-Hexamethyl-
1,2,3,8,9,13,14,15,15a,22,23,28b-dodecahydro-2,4a:11a,14-
diepoxytetrabenzo[f,h,q,s][1,5,11,15]tetraoxacycloicosine-
4,5,11,12(7H,21H)-tetraone (11a)
Following the typical procedure for 10a from 3b and 9a gave 11a
as a white solid; yield: 88 mg (58%); mp 202–204 °C.
IR (neat): 2973, 1767, 1742, 1495, 1454, 1333, 1243, 1130, 1054,
842, 731 cm–1.
Crystal data for 10a: (CCDC 900352) C37H42O12, M = 678.71, 0.17
× 0.11 × 0.08 mm, triclinic, space group P-1 with a = 9.2900(9) Å,
b = 12.2162(11) Å, c = 31.952(3) Å, α = 99.062(2), β = 95.660(2),
γ = 99.688(2), V = 3500.5(6) Å3, T = 100(2) K, R1 = 0.0579, wR2 =
0.1393 on observed data, z = 4, Dcalcd = 1.288 mg cm–3, F(000) =
1440, absorption coefficient = 0.096 mm–1, λ = 0.71073 Å, 12084
reflections were collected on a smart apex CCD single crystal dif-
fractometer 9283 observed reflections [I ≥ 2σ (I)]. The largest dif-
ference peak and hole = 1.024 and –0.319 eÅ–3, respectively. The
structure was solved by direct methods and refined by full-matrix
least squares on F2 using SHELXL–97 software.
1H NMR (400 MHz, CDCl3): δ = 0.88–0.91 (m, 2 H, CH2), 1.10 (s,
6 H, CH3), 1.12 (s, 6 H, CH3), 1.48 (s, 6 H, CH3), 1.70 (dd, J1 = 13.1
Hz, J2 = 6.2 Hz, 2 H, CH2), 2.17–2.26 (m, 2 H, CH2), 2.63 (dd, J1 =
13.1 Hz, J2 = 9.1 Hz, 2 H, CH2), 2.73 (dt, J1 = 13.1 Hz, J2 = 6.6 Hz,
2 H, OCH2), 3.70 (dt, J1 = 13.7 Hz, J2 = 6.9 Hz, 2 H, OCH2), 3.96
(dd, J1 = 9.1 Hz, J2 = 6.2 Hz, 2 H, CH), 4.01 (dt, J1 = 8.7 Hz, J2 =
3.2 Hz, 2 H, OCH2), 4.21–4.27 (m, 2 H, OCH2), 6.81 (td, J1 = 7.6
Hz, J2= 0.8 Hz, 2 H, HAr), 6.90 (dd, J1 = 8.4 Hz, J2 = 0.8 Hz, 2 H,
HAr), 7.14 (td, J1 = 8.4 Hz, J2 = 1.6 Hz, 2 H, HAr), 7.37 (dd, J1 = 8.0
Hz, J2 = 1.6 Hz, 2 H, HAr).
13C NMR (100 MHz, CDCl3): δ = 16.7 (CH3), 20.0 (CH3), 20.7
(CH3), 26.3 (CH2), 29.7 (CH2), 38.7 (CH), 44.0 (CH2), 50.4 (Cq),
61.2 (OCH2), 63.3 (OCH2), 87.2 (Cq), 93.8 (Cq), 111.0 (=CH), 121.3
(=CH), 127.3 (=CH), 128.4 (=CH), 129.9 (Cq), 155.5 (Cq), 164.9
(COO), 210.9 (C=O).
(3S,4aR,17bR,19S,21aS,27aS)-2,2,3,19,20,20-Hexamethyl-
2,3,11,12,19,20,24,25-octahydro-1H-3,27a:19,21a-
diepoxydibenzo[h,o]dipyrano[3,2-f:2′,3′-q][1,4,10,14]tetraoxa-
cyclononadecine-1,21,22,27(4aH,10H,17bH)-tetraone (10b)
Following the typical procedure for 10a from 3a and 8a gave 11b
as a white solid; yield: 86 mg (56%); mp 205–207 °C.
HRMS (ESI): m/z [M + Na]+ calcd for C38H44O10: 683.2832; found:
683.2834.
IR (neat): 2972, 1782, 1755, 1689, 1600, 1459, 1288, 1244, 756
cm–1.
(3R,4aR,17bR,19R,21aS,27aS)-2,2,3,19,20,20-Hexamethyl-
2,3,4,4a,11,12,17b,18,19,20,24,25-dodecahydro-1H-
3,27a:19,21a-diepoxytetrabenzo[f,h,o,q][1,4,10,14]tetraoxacy-
clononadecine-1,21,22,27(10H)-tetraone (11b)
Following the typical procedure for 11a from 3a and 9a gave 11b
as a white solid; yield: 84 mg (55%); mp 191–193 °C.
1H NMR (400 MHz, CDCl3): δ = 1.11 (s, 6 H, CH3), 1.20 (s, 6 H,
CH3), 1.68 (s, 6 H, CH3), 2.20–2.30 (m, 4 H, CH2), 2.32–2.34 (m, 2
H, OCH2), 3.97–4.01 (m, 2 H, OCH2), 4.29–4.40 (m, 2 H, OCH2),
5.55 (s, 2 H, OCH), 6.90 (q, J = 7.6 Hz, 4 H, HAr), 7.27 (dt, J1 = 7.6
Hz, J2 = 1.6 Hz, 2 H, HAr), 7.45 (dd, J1 = 7.6 Hz, J2 = 1.6 Hz, 2 H,
HAr).
13C NMR (100 MHz, CDCl3): δ = 14.7 (CH3), 19.5 (CH3), 21.0
(CH3), 29.5 (CH2), 53.2 (Cq), 62.8 (OCH2), 64.8 (OCH2), 72.0
(OCH), 91.8 (Cq), 110.6 (=CH), 112.9 (Cq), 121.0 (=CH), 123.4
(Cq), 128.7 (=CH), 130.6 (=CH), 155.8 (Cq), 162.4 (COO), 206.5
(C=O).
IR (neat): 2978, 2931, 2361, 1743, 1455, 1377, 1284, 1114, 1052,
863, 733 cm–1.
1H NMR (400 MHz, CDCl3): δ = 1.10 (s, 12 H, CH3), 1.48 (s, 6 H,
CH3), 1.67 (dt, J1 = 12.2 Hz, J2 = 2.4 Hz, 2 H, OCH2), 1.75 (dd, J1 =
13.0 Hz, J2 = 6.4 Hz, 2 H, CH2), 2.20–2.23 (m, 2 H, CH2), 2.63 (dd,
J1 = 13.0 Hz, J2 = 9.2 Hz, 2 H, CH2), 4.01–4.02 (m, 2 H, OCH2),
4.04 (dd, J1 = 9.24 Hz, J2 = 6.4 Hz, 2 H, CH2), 4.25–4.34 (m, 2 H,
OCH2), 4.32 (dd, J1 = 10.0 Hz, J2 = 2.4 Hz, 2 H, OCH2), 6.81 (td,
J1 = 7.6 Hz, J2 = 0.8 Hz, 2 H, HAr), 6.90 (dd, J1 = 8.4 Hz, J2 = 0.8
Hz, 2 H, HAr), 7.17 (td, J1 = 8.4 Hz, J2 = 1.6 Hz, 2 H, HAr), 7.33 (dd,
J1 = 7.6 Hz, J2 = 1.6 Hz, 2 H, HAr).
13C NMR (100 MHz, CDCl3): δ = 16.7 (CH3), 20.1 (CH3), 20.6
(CH3), 29.6 (CH2), 39.3 (CH), 43.6 (CH2), 50.4 (Cq), 62.7 (OCH2),
64.2 (OCH2), 87.1 (Cq), 93.1 (Cq), 110.7 (=CH), 121.0 (=CH), 127.4
(=CH), 128.57 (Cq), 128.64 (=CH), 155.6 (Cq), 164.7 (COO), 210.0
(C=O).
HRMS (ESI): m/z [M + Na]+ calcd for C35H38O12: 673.2261; found:
673.2258.
(2S,4aS,11aS,14S,15aR,28bR)-2,3,3,13,13,14-Hexamethyl-
2,3,8,9,13,14,22,23-octahydro-2,4a:11a,14-diepoxydiben-
zo[f,s]dipyrano[2,3-h:3′,2′-q][1,5,11,15]tetraoxacycloicosine-
4,5,11,12(7H,15aH,21H,28bH)-tetraone (10c)
Following the typical procedure for 10a from 3b and 8a gave 10c as
a white solid; yield: 75 mg (50%); mp 210–212 °C.
IR (neat): 2965, 2926, 1780, 1750, 1689, 1601, 1400, 1334, 1262,
1056, 802, 750 cm–1.
HRMS (ESI): m/z [M + Na]+ calcd for C37H42O10: 669.2676; found:
669.2673.
1H NMR (400 MHz, CDCl3): δ = 0.78–0.83 (m, 2 H, CH2), 1.13 (s,
6 H, CH3), 1.20 (s, 6 H, CH3), 1.67 (s, 6 H, CH3), 2.21–2.22 (m, 2
H, CH2), 2.91–2.97 (m, 2 H, OCH2), 3.74–3.80 (m, 2 H, OCH2),
3.95–3.98 (m, 2 H, OCH2), 4.30–4.36 (m, 2 H, OCH2), 5.50 (s, 2 H,
OCH), 6.87 (t, J = 7.6 Hz, 2 H, HAr), 6.93 (d, J = 8.0 Hz, 2 H, HAr),
7.26 (dt, J1 = 8.4 Hz, J2 = 1.6 Hz, 2 H, HAr), 7.47 (dd, J1 = 7.6 Hz,
J2 = 1.6 Hz, 2 H, HAr).
13C NMR (100 MHz, CDCl3): δ = 14.8 (CH3), 19.5 (CH3), 21.0
(CH3), 26.6 (CH2), 29.4 (CH2), 53.1 (Cq), 61.6 (OCH2), 63.1
(OCH2), 71.4 (OCH), 92.2 (Cq), 111.2 (=CH), 112.9 (Cq), 121.1
(=CH), 124.3 (Cq), 128.7 (=CH), 130.5 (=CH), 156.1 (Cq), 162.6
(COO), 207.4 (C=O).
(4bR,6R,8aS,20aS,23R,24aR)-6,7,7,22,22,23-Hexamethyl-
4b,5,6,7,11,12,13,14,15,16,17,18,22,23,24,24a,30,31,32,33,34,35-
docosahydro-6,8a:20a,23-diepoxytetraben-
zo[c,e,o,q][1,7,14,20]tetraoxacyclooctacosine-8,9,20,21-tetra-
one (11c)
Following the typical procedure for 11a from 3d and 9b gave 11c
as a white solid; yield: 91 mg (60%); mp 215–217 °C.
IR (neat): 2929, 2856, 1769, 1745, 1493, 1454, 1333, 1245, 1110,
1086, 754 cm–1.
1H NMR (400 MHz, CDCl3): δ = 1.00–1.20 (m, 24 H), 1.48 (s, 6 H,
CH3), 1.67 (dd, J1 = 13.2 Hz, J2 = 6.0 Hz, 4 H, CH2), 1.79 (s, 6 H,
CH2), 2.63 (dd, J1 = 12.8 Hz, J2 = 10.0 Hz, 2 H, CH), 3.63–3.65 (m,
2 H, CH2), 3.84–3.97 (m, 8 H, OCH2), 6.81 (dd, J1 = 16 Hz, J2 = 7.2
Hz, 4 H, HAr), 7.07–7.10 (m, 2 H, HAr), 7.42 (d, J = 7.2 Hz, 2 H,
HAr).
HRMS (ESI): m/z [M + Na]+ calcd for C36H40O12: 687.2417; found:
687.2412.
© Georg Thieme Verlag Stuttgart · New York
Synthesis 2013, 45, 2034–2042